Tu

TuBerculosis Vaccine Initiative (TBVI)

Research-Services

Company Tagline

Accelerating TB vaccine Research & Development through partnership

Industry Category
Research-Services
Company Description

TuBerculosis Vaccine Initiative (TBVI) is dedicated to accelerating TB vaccine research and development through strategic partnerships. Located at Runderweg 6, 8219 PK Lelystad, NL, TBVI operates as a non-profit foundation, integrating and prioritizing research and development efforts to discover new TB vaccines and biomarkers for global use.

TBVI provides essential services to support the R&D efforts of its consortium partners, which include project identification, design, and development, project management, resource mobilization, knowledge development, exchange, and networking, and technical advice and support for product and clinical development. TBVI’s commitment extends to ensuring the accessibility and affordability of TB vaccines for the developing world, making it a statutory objective of the organization.

TuBerculosis Vaccine Initiative (TBVI) innovates and diversifies the pipeline for TB vaccines and accelerates the most promising vaccine and biomarker candidates. The organization seeks to align its portfolio management approach with other global efforts. We invite the management of TuBerculosis Vaccine Initiative (TBVI) to create a customized and exclusive company showcase and product listing on our platform.

Key Personnel / Employees
Ingrid Murillo Jelsbak (Directora de Investigación Clínica. Biofabri) Gerald Voss Arjen Sloots Anne Meinema

Compare Companies Side by Side

Compare TuBerculosis Vaccine Initiative (TBVI) with 3 companies in Research-Services

4 Companies
Comparison Field
Tu
TuBerculosis Vaccine Init...
Main Company
Elizabeth Glaser Pediatric AIDS Foundation
Elizabeth Glaser Ped...
View Profile
Gavi, the Vaccine Alliance
Gavi, the Vaccine Al...
View Profile
Asian Liver Center at Stanford University
Asian Liver Center a...
View Profile
Founded Year
1988 2000 1996
Company Size
1,001-5,000 201-500 11-50
City
Washington, District of Columbia Le Grand-Saconnex, Geneva Palo Alto, CA
Country
United States Switzerland United States
Skills & Keywords Comparing with main company
13 Total Skills
Tuberculosis vaccines Vaccine research Global health Immunization Biomarker discovery Product development partnership TBVI tuberculosis vaccines advocacy immunisation research global health
2 Total 2 Unique
Unique Skills:
program implementation technical assistance
5 Total 5 Unique
Unique Skills:
#VaccinesWork COVID-19 international development public health public private partnership
10 Total 10 Unique
Unique Skills:
cancer research collaboration community health community outreach hepatitis B liver cancer +4
4
Total Companies
1988
Oldest Founded
2
Countries
30
Unique Skills

Similar Companies

Other organizations in the same industry

Laval Science
Research-Services

A collaborative research company focusing on financial markets and using advanced quantitative techn...

VRAIN - Valencian Research Institute for Artificia...
Research-Services

Excellence Research on Responsible Artificial Intelligence

Valencia, Valencia
K-INN Tech s.r.l.
Research-Services

Research and development in outsourcing, for the companies of the chemical, environmental and energy...

Padova, Veneto
Italy
Berkeley Existential Risk Initiative
Research-Services

Our mission is to improve human civilization’s long-term prospects for survival and flourishing.

Berkeley, CA
United States

Alternative Company Names

This company is also known as

TuBerculosis Vaccine Initiative (TBVI) 结核病疫苗倡议 (TBVI) तपेदिक वैक्सीन पहल (टीबीवीआई) Iniciativa de Vacunas contra la Tuberculosis (TBVI) مبادرة لقاح السل (TBVI) টিউবারকুলোসিস ভ্যাকসিন ইনিশিয়েটিভ (টিবিভিআই) Initiative de vaccin contre la tuberculose (TBVI) Инициатива по вакцине против туберкулеза (TBVI) Iniciativa de Vacina contra a Tuberculose (TBVI)